West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 19.67%

West Pharmaceutical Services, Inc. EBIT Margin is 19.67% for the Trailing 12 Months (TTM) ending March 31, 2025, a -13.88% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 22.84%, a -10.75% change year over year.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 25.59%, a -4.95% change year over year.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 26.93%, a 21.83% change year over year.
  • West Pharmaceutical Services, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 22.10%, a 33.82% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin